Sofia Koukidou
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study.
Journal: Allergy and asthma proceedings
Published: December 31, 2024
Patients Hospitalized for COVID-19 in the Periods of Delta and Omicron Variant Dominance in Greece: Determinants of Severity and Mortality.
Journal: Journal of clinical medicine
Published: August 15, 2023
Association of Broad-Spectrum Antibiotic Therapy and Vitamin E Supplementation with Vitamin K Deficiency-Induced Coagulopathy: A Case Report and Narrative Review of the Literature.
Journal: Journal of personalized medicine
Published: July 24, 2023
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: June 20, 2023
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Journal: Cytokine
Published: October 09, 2022
Predictors of Mortality in Tocilizumab-Treated Severe COVID-19.
Journal: Vaccines
Published: May 02, 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response.
Journal: Allergy
Published: March 20, 2022
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics.
Journal: The journal of allergy and clinical immunology. In practice
Published: February 13, 2022
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis.
Journal: International archives of allergy and immunology
Published: April 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026